Trial details
Electively Combining Two Ablative RadioTherapy Treatments for Favorable Risk Prostate Cancer Patients (EARTH)
To find out more about this trial and your cancer treatment options, please speak with your doctor.
Trial short name: EARTH
Official title: Electively Combining Two Ablative RadioTherapy Treatments for Favorable Risk Prostate Cancer Patients (EARTH)
Principal Investigator: Dr. Andrew Loblaw
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase:
Intervention:
Registration #:
Contact e-mail: cancerclinicaltrials@sunnybrook.ca